Introduction

Ozelle is a digital diagnostics solution provider originated in 2014 from a laboratory in Silicon Valley, USA. We focus on empowering medical and veterinary diagnostics through cutting-edge AI and IoT technologies.

50000+

Units Installed

40M+

Sample Tested

5000+

Monthly Production Capacity

“Over the past decade, we have pursued one vision: to redefine diagnostics, making healthcare more precise, more accessible, and future-ready.”

Shuang Hu

Chairman & Founder, Ozelle

Vision & Mission

At Ozelle, our mission is to reshape diagnostics by transforming complex laboratory workflows into integrated, intelligent solutions. Guided by the vision of making diagnostics accessible across all medical scenarios—from major hospitals to community clinics and rural practices—we create end-to-end solutions that combine innovation, precision, and accessibility. Our focus is not only on developing devices, but on building diagnostic ecosystems that empower healthcare providers to deliver better outcomes, ensuring that quality healthcare is truly within reach for everyone.

Branches

R&D Office

Frankfurt, Germany

Office

Abu Dhabi, UAE

Marketing Center

Shenzhen, China

Manufacturing Center

Changsha, China

Our History

2014

Our history traces back to 2014, when a research team composed of postdoctoral fellows and scientists from multiple prestigious universities and institutions in the United States, including two postdoctoral fellows from the Lawrence Berkeley National Laboratory, a postdoctoral fellow from the California Department of Public Health, a professor from McMaster University, as well as Dr. Joshua Robinson and Academician Hongjie Dai from the U.S. National Academy of Sciences, was established in Joinn Innovation Park, located in the heart of Silicon Valley, California, USA.In November of same year, we had research cooperation with Nirmidas and StartX (Stanford’s Accelerator) on Personal and Portable Health Diagnostic Testing. In the following year, our first colloidal analyzer passed the test from DCN, the authorized device test organization in the US.

2016

Our research and development continued in the next few years with encouraging results by steady progress. In 2016, we developed colloidal gold test strip product antibodies in collaboration with ProMab and 2 patents obtained in the same year. In the next 3 years, we updated the version each year from Colloidal analyzer 2.0 version, Second Generation of colloidal analyzer: EHB-2.3 to version EHB3.0-EBH3.1.

2021

When the COVID pandemic prevailed in 2020, our core team decided to move back to Germany. The R&D continued until our first hematology analyzer based on cell morphology technology came alive in 2021. Our brand story started by then…

Login

Require a Demo

Kindly provide your contact details so that we can reach out to you and arrange a demonstration. You can also reach us via the phone number and email address provided at the bottom.

info@ozellepoct.com